Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease, post-stroke walking difficulty, migraine, and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.

Stock Chart


Date Filing Description Download
10/17/16 CT ORDER Confidential Treatment Order
10/13/16 8-K Current report filing
10/11/16 4 Statement of Changes in Beneficial Ownership
10/05/16 4 Statement of Changes in Beneficial Ownership

Stock Quote

ACOR (Common Stock) $ 20.10 -0.10 (-0.5%) Volume: 344,611 MORE October 21, 2016

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *

Enter the code shown above.